| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |